100 %

john paul

President

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis lacinia porttitor ipsum, at gravida nunc ultricies quis. Quisque congue leo est, a venenatis ex congue a. Vivamus magna est, fermentum sed fermentum dapibus.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis lacinia porttitor ipsum, at gravida nunc ultricies quis. Quisque congue leo est, a venenatis ex congue a. Vivamus magna est, fermentum sed fermentum dapibus.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis lacinia porttitor ipsum, at gravida nunc ultricies quis. Quisque congue leo est, a venenatis ex congue a. Vivamus magna est, fermentum sed fermentum dapibus.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis lacinia porttitor ipsum, at gravida nunc ultricies quis. Quisque congue leo est, a venenatis ex congue a. Vivamus magna est, fermentum sed fermentum dapibus.

Feature Stories

  • 30 October 2017

    Trivitron Healthcare in association with NeoGen labs hosted NBS Symposium 2017

    Trivitron Healthcare in association with NeoGen Labs hosted the 2017 Newborn Screening Symposium on October 30, 2017 in Bangalore. Newborn Screening (NBS) is a test performed on babies, normally 24 to 72 hours after birth, to identify "Inborn Errors of Metabolism", or IEMs, and to treat them if they are identified for before they are adversely impacted. Trivitron has introduced state of the art technology in India to support NBS to improve neonatal care and ensure babies start their life healthy.

  • Visit Site
Previous
Next